FIELD: pharmaceuticals.
SUBSTANCE: invention relates to tritiated 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-one of the formula I.
(I).
EFFECT: expansion of the range of labeled analogs of physiologically active compounds, namely, 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3_3_1]nonan-9-one, which can find its application in medicine for the treatment of Alzheimer's and other neurodegenerative diseases.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3.3.1]NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND USE THEREOF | 2015 |
|
RU2613071C1 |
N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3,3,1]NONANES WITH PHARMACOLOGICAL EFFECT, PHARMACOLOGICAL COMPOSITIONS ON THEIR BASE, AND APPLICATION METHOD | 2006 |
|
RU2333211C1 |
TRITIUM-LABELED ACYL-COENZYME A | 2006 |
|
RU2305104C1 |
UNIFORMLY TRITIUM-LABELED 4,4-DIFLUORO-N-{(1S)-3-[3-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO[3,2,1]OCT-8-YL]-1-PHENYLPROPYL}CYCLOHEXANE CARBODIIMIDE | 2008 |
|
RU2368613C1 |
ALICYCLIC DERIVATIVES OF N,N'-SUBSTITUTED 3,7-DIAZABICYCLO[3,3,1]NONANES, HAVING PHARMACOLOGICAL ACTIVITY, AND MEDICINAL AGENTS ON THEIR BASIS | 2011 |
|
RU2489436C2 |
CHLOROHEXIDINE HIGHLY LABELED WITH TRITIUM | 2005 |
|
RU2309929C2 |
TRITIUM-LABELLED 3-[5-(2-FLUROPHENYL)-1,2,4-OXADIAZOL-3-YL]BENZOIC ACID | 2009 |
|
RU2398770C1 |
UNIFORMLY TRITIUM-LABELLED PYRO-Glu-His-Pro-NH | 2013 |
|
RU2513852C1 |
UNIFORMLY MARKED WITH TRITIUM TILOSIN | 2008 |
|
RU2360896C1 |
2-AMINO-4-(β-HYDROXYETHYLAMINO)ANISOLE UNIFORMLY LABELED WITH TRITIUM | 2005 |
|
RU2291142C1 |
Authors
Dates
2018-10-05—Published
2017-10-10—Filed